284 results
Page 4 of 15
8-K
EX-99.1
5jgqvn0el5v9cg
5 May 21
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:28pm
8-K
EX-99.2
0sp3 a8o32fo53kjx
5 May 21
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:28pm
8-K
EX-99.1
3tnq9rrcq 4j
29 Apr 21
Other Events
4:48pm
8-K
EX-99.1
q43 bcjoe6987
21 Apr 21
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
4:36pm
8-K
EX-99.1
3pp7fa2rebokhmb5
14 Apr 21
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
4:16pm
8-K
EX-99.1
7rizwkn
23 Mar 21
Data show greater GH response in pediatric growth hormone deficiency (PGHD) from LUM-201 than standard GH secretagogues
4:19pm
8-K
EX-99.1
4bv15tzatq3cy fi
9 Mar 21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
4:26pm
8-K
EX-99.2
ab91n
9 Mar 21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
4:26pm
8-K
EX-99.1
db7gq7g6ywy
4 Mar 21
Other Events
9:09am
8-K
EX-99.1
uyyak wjmg6i139fk71t
2 Mar 21
Other Events
4:30pm
8-K
EX-10.1
ulq6f6
30 Dec 20
Entry into a Material Definitive Agreement
4:44pm
424B5
k8o1007v koow00r4
30 Dec 20
Prospectus supplement for primary offering
4:36pm
8-K
8mmvyp
21 Dec 20
Other Events
4:34pm
8-K
EX-99.2
y7d7h
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
EX-99.1
f9v1kxcl
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm